| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
Portfolio, Strategy and Value Management | |
| |
February 22, 2008 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, DIA, 800 Enterprise Rd., Suite 200, Horsham, PA, USA
May 21 2008
This course provides an integrated view of how corporate strategy is delivered through the portfolio of new and lifecycle drug projects. Set in a small group setting, this highly interactive course uses a case study approach to help attendees develop real-world skills in building viable portfolio, strategy, and drug value processes. COURSE HIGHLIGHTS·Standard processes for portfolio, strategy, and drug value management.·How to translate generic processes into pragmatic and viable processes.·Organizational approaches to drug value creation.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
Peter Harpum, MS Director Harpum Consulting Ltd.United Kingdom.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=16182&eventType=Training%20Course
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|